Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MorphinOgel: Oral Morphine Gel for Chemotherapy-Induced Oral Mucositis
NCT02173756Phase 3Terminated
- Sponsor
- Strasbourg University Hospital
- Start
- Jun 2014
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in oral mucositis (OM) comparing oral morphine gel with placebo gel (2 arms). Primary endpoint: Change in pain of mucositis before and after meal. Started Jun 2014; status: terminated.
02
Drugs
morphine hydrochloride
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT02173756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02173756.